Current Diabetes Reviews (CDR)

Current Diabetes Reviews is a peer‑reviewed, international journal dedicated to publishing comprehensive reviews, mini‑reviews, and original research focused on diabetes and related metabolic disorders. The journal serves as a platform for researchers, clinicians, and healthcare professionals to share up-to-date scientific knowledge and clinical insights on the pathogenesis, diagnosis, prevention, and treatment of diabetes. Its scope includes type 1 and type 2 diabetes, gestational diabetes, prediabetes, and metabolic syndrome, along with associated complications such as cardiovascular disease, nephropathy, neuropathy, retinopathy, and other micro- and macrovascular conditions. The journal also emphasizes translational research, highlighting studies in pharmacology, endocrinology, molecular biology, and innovative therapeutic interventions. In addition to clinical and experimental research, it covers epidemiological studies, lifestyle interventions, and public health strategies aimed at managing and preventing diabetes. Published by Bentham Science Publishers, Current Diabetes Reviews maintains rigorous peer-review standards to ensure scientific accuracy, relevance, and quality. Indexed in major databases including PubMed, Scopus, and EMBASE, the journal provides broad visibility and accessibility for authors and readers worldwide. With a monthly publication schedule, it facilitates timely dissemination of cutting-edge knowledge and fosters collaboration among academics, clinicians, and industry professionals, advancing both research and clinical practice in diabetes care globally.

Current Diabetes Reviews (CDR) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pathogenesis, pharmacology, therapy of diabetes, Endocrine and Autonomic Systems, Endocrinology, Diabetes and Metabolism, Epidemiology and clinical care of diabetic patients, Pancreatic islet dysfunction, insulin resistance , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1573-3998, E-ISSN: 1875-6417, Established: 2005, Impact Factor: 1.9
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE